A study of community-level antibiotic use in patients in four low- and middle-income countries (LMICs) found frequent use of broad-spectrum antibiotics considered at risk of becoming ineffective owing to rising antibiotic resistance, an international team of researchers reported today in Clinical Microbiology and Infection.
A study yesterday found that employment-related exposure to SARS-CoV-2, the virus that causes COVID-19, endangers workers and their household members.
Daily infectious disease (ID) consultation in an Italian hospital was associated with reduced antibiotic consumption compared with weekly ID consultation, Italian researchers reported late last week in BMC Infectious Diseases.
The use of point-of-care C-reactive protein (CRP) tests in primary care practices reduced the odds of prescribing antibiotics for cough by 21%, a non-significant but clinically relevant reduction, researchers reported yesterday in Eurosurveillance.
Health Canada yesterday announced that a rare variant H1N2 (H1N2v) influenza case has been confirmed in Alberta, marking the province's only flu case reported so far this season.
A Duke University study yesterday in Clinical Infectious Diseases found a 77% infection rate in children who were close contacts of a COVID-19 case, providing evidence for efficient viral transmission in children. Hispanic ethnicity and having a SARS-CoV-2–infected sibling were risk factors, but asthma was associated with reduced risk.
Eight COVID-19 patients in Texas who have secondary carbapenem-resistant Acinetobacter baumannii (CRAB) infections are receiving investigational bacteriophage therapy from biotechnology company Adaptive Phage Therapeutics (APT), company officials announced yesterday.
Hospital room floors could be an underappreciated source of healthcare-associated pathogen spread, including those resistant to antibiotics, according to a study today in Infection Control and Hospital Epidemiology.
Yesterday the Centers for Disease Control and Prevention (CDC) reported two separate Escherichia coli O157:H7 outbreaks in the United States. Neither has an identified source, and one has already proved deadly.
Sports cardiologists in JAMA Cardiology yesterday updated guidance for athletes returning to play (RTP) after COVID-19 infection. The authors recommended a risk stratification approach, with screening for cardiac injury only for athletes with severe disease or preexisting cardiovascular (CV) conditions.
